Loading...
Loading...
India's atorvastatin imports from MALAYSIA total $734 across 3 shipments from 2 foreign suppliers. SAVI CLINICALS FZ LLC leads with $498 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for atorvastatin โ a concentrated sourcing relationship with select suppliers from MALAYSIA.

SAVI CLINICALS FZ LLC is the leading Atorvastatin supplier from MALAYSIA to India, with import value of $498 across 1 shipments. The top 5 suppliers โ SAVI CLINICALS FZ LLC, NOVUGEN PHARMA SDN. BHD โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SAVI CLINICALS FZ LLC | $498 | 1 | 67.9% |
| 2 |
| NOVUGEN PHARMA SDN. BHD |
| $235 |
| 2 |
| 32.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $498 | 1 | 67.9% |
| 2 | LAMBDA THERAPEUTIC RESEARCH LIMITED | $235 | 2 | 32.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Atorvastatin suppliers from MALAYSIA to India include SAVI CLINICALS FZ LLC, NOVUGEN PHARMA SDN. BHD. The leading supplier is SAVI CLINICALS FZ LLC with import value of $498 USD across 1 shipments. India imported Atorvastatin worth $734 USD from MALAYSIA in total across 3 shipments.
India imported Atorvastatin worth $734 USD from MALAYSIA across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Atorvastatin sourced from MALAYSIA include MSN LABORATORIES PRIVATE LIMITED, LAMBDA THERAPEUTIC RESEARCH LIMITED. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $498 in imports across 1 shipments.
The total value of Atorvastatin imports from MALAYSIA to India is $734 USD, across 3 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists